A carregar...
Pathologic complete response and disease-free survival are not surrogate endpoints for 5-year survival in rectal cancer: an analysis of 22 randomized trials
BACKGROUND: We performed a literature-based analysis of randomized clinical trials to assess the pathologic complete response (pCR) (ypT0N0 after neoadjuvant therapy) and 3-year disease-free survival (DFS) as potential surrogate endpoints for 5-year overall survival (OS) in rectal cancer treated wit...
Na minha lista:
| Publicado no: | J Gastrointest Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5334047/ https://ncbi.nlm.nih.gov/pubmed/28280607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.11.03 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|